Anavex Life Sciences Corp (AVXL)

[Anshu2]

In short, the market is excited about:

(i) AD biomarker data which CM alluded to in April -- but is now promising to PR sometime this year. WHY THE 6-MONTH DELAY (even after having seen the data somewhat)?

(ii) Possibility that the extension study may be the confirmation study -- if the biomarker data can be used for AA. I find this extremely unlikely -- but doesn't matter, as long as AVXL gets the AA based on biomarker data.

(iii) Pending EXCELLENCE topline data.

However, the above don't mitigate the main issues with AVXL: (i) Why the delays? To me they point do data engineering. (ii) Difficult to ignore the possibility that CM will continue to manufacture endpoints/outcome measures, lie (or say half-truths), and delay and delay and delay ..

Nevertheless, a very strong/perfect day today. Strong volume (but not explosive, which is great), close at the HOD, and most importantly, delayed reaction to the CC (plus, after a shakedown). So, very strong technically.